Literature DB >> 20653106

Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis.

Jayaprakasam Madhumathi1, Prabhu Rajaiah Prince, Gandhirajan Anugraha, Pote Kiran, Donthamsetty Nageswara Rao, Maryada Venkata Rami Reddy, Perumal Kaliraj.   

Abstract

Although multi-epitope vaccines have been evaluated for various diseases, they have not yet been investigated for lymphatic filariasis. Here, we report for the first time identification of two immunodominant B epitopes (TRXP1 and TRXP2) from the antioxidant Brugia malayi thioredoxin by studying their immune responses in mice model and human subjects. TRXP1 was also found to harbor a T epitope recognized by human PBMCs and mice splenocytes. Further, the epitopic peptides were synthesized as a single peptide conjugate (PC1) and their prophylactic efficacy was tested in a murine model of filariasis with L3 larvae. PC1 conferred a significantly high protection (75.14%) (P < 0.0001) compared to control (3.7%) and recombinant TRX (63.03%) (P < 0.018) in experimental filariasis. Our results suggest that multi-epitope vaccines could be a promising strategy in the control of lymphatic filariasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653106     DOI: 10.1016/j.vaccine.2010.05.012

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

Review 1.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Multivalent fusion protein vaccine for lymphatic filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Abhilash Kumble Samykutty; Gnanasekar Munirathinam; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  Vaccine       Date:  2012-10-02       Impact factor: 3.641

3.  Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis.

Authors:  Christiana Immanuel; Aparnaa Ramanathan; Malathi Balasubramaniyan; Vishal Kishor Khatri; Nitin Purushottam Amdare; Donthamsetty Nageswara Rao; Maryada Venkata Rami Reddy; Kaliraj Perumal
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

4.  Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation.

Authors:  Gajalakshmi Dakshinamoorthy; Ramaswamy Kalyanasundaram
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641

5.  Theoretical analysis of the neuraminidase epitope of the Mexican A H1N1 influenza strain, and experimental studies on its interaction with rabbit and human hosts.

Authors:  Paola Kinara Reyes Loyola; R Campos-Rodríguez; Martiniano Bello; S Rojas-Hernández; Mirko Zimic; Miguel Quiliano; Verónica Briz; M Angeles Muñoz-Fernández; Luis Tolentino-López; Jose Correa-Basurto
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

6.  In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes.

Authors:  Jose Rojas-Caraballo; Julio López-Abán; Luis Pérez del Villar; Carolina Vizcaíno; Belén Vicente; Pedro Fernández-Soto; Esther del Olmo; Manuel Alfonso Patarroyo; Antonio Muro
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

7.  Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Gnanasekar Munirathinam; Kristen Stoicescu; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

8.  Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model.

Authors:  Jyoti Gupta; Manisha Pathak; Sweta Misra; Shailja Misra-Bhattacharya
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

9.  Evaluating the Vaccine Potential of a Tetravalent Fusion Protein (rBmHAXT) Vaccine Antigen Against Lymphatic Filariasis in a Mouse Model.

Authors:  Nikhil Chauhan; Vishal Khatri; Priyankana Banerjee; Ramaswamy Kalyanasundaram
Journal:  Front Immunol       Date:  2018-07-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.